NAT9 antibody (AA 1-207)
Quick Overview for NAT9 antibody (AA 1-207) (ABIN6144386)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-207
-
Sequence
- MRLNQNTLLL GKKVVLVPYT SEHVPSRYHE WMKSEELQRL TASEPLTLEQ EYAMQCSWQE DADKCTFIVL DAEKWQAQPG ATEESCMVGD VNLFLTDLED LTLGEIEVMI AEPSCRGKGL GTEAVLAMLS YGVTTLGLTK FEAKIGQGNE PSIRMFQKLH FEQVATSSVF QEVTLRLTVS ESEHQWLLEQ TSHVEEKPYR DGSAEPC
-
Cross-Reactivity
- Human
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-207 of human NAT9 (NP_056469.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- IF,1:50 - 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NAT9 (N-Acetyltransferase 9 (NAT9))
-
Alternative Name
- NAT9
-
Background
- NAT9,EBSP,hNATL,Epigenetics & Nuclear Signaling,Cancer,Signal Transduction,Endocrine & Metabolism,Amino acid metabolism,NAT9
-
Molecular Weight
- 23 kDa
-
Gene ID
- 26151
-
UniProt
- Q9BTE0
Target
-